178
Participants
Start Date
October 31, 2008
Primary Completion Date
October 31, 2012
Study Completion Date
January 31, 2013
NKTR-102 q14d
NKTR-102 given on a q14 day schedule
NKTR-102 q21d
NKTR-102 given on a q21 day schedule
Investigator Site - Charlottesville, Charlottesville
Investigator Site - Winston-Salem, Winston-Salem
Investigator Site - West Palm Beach, West Palm Beach
Investigator Site - Nashville, Nashville
Investigator Site - Lansing, Lansing
Investigator Site - Iowa City, Iowa City
Investigator Site - Oklahoma City, Oklahoma City
Investigator Site - Los Angeles, Los Angeles
Investigator Site - Higland, Highland
Investigator Site - Newport Beach, Newport Beach
Investigator Site - East Providence, East Providence
Investigator Site - Gent, Ghent
Investigator Site - Leuven, Leuven
Investigator Site - Liege, Liège
Investigator Site - Wilrijk, Wilrijk
Investigator Site - Middlesex, Middlesex
Investigator Site - Coventry, Coventry
Investigator Site - Dundee, Dundee
Investigator Site - Glasgow, Glasgow
Investigator Site - Newcastle Upon Tyne, Newcastle upon Tyne
Lead Sponsor
Nektar Therapeutics
INDUSTRY